SUMMARY One hundred patients with vulvovaginal candidosis were entered in a double-blind trial to compare the effect of six days' local treatment with clotrimazole with that of the same treatment plus 10 days' oral treatment with nystatin. No significant differences were detected in the rate of cure or relapse between the treatment groups. The cure rate was lowest and the relapse rate highest in patients in whom vaginal candidosis had last been diagnosed during the preceding 12 months.
Introduction
Patients and methods
Vaginal infection with Candida albicans is a common condition (Oriel et al., 1972; Hilton and Warnock, 1975) . Most, if not all, patients with this infection also harbour this fungus in their digestive tract (Hilton and Warnock, 1975; Miles et al., 1977) , and it has been suggested that the failure of a significant proportion of such patients to respond to local treatment, and the need of others for prolonged or repeated courses of treatment, is due-in part at least -to reinfection from their intestinal tract. Indeed, Miles et al. (1977) suggested that the intestinal reservoir must be eliminated if the genital infection is to be cured. Oral treatment with nystatin has been shown to reduce intestinal colonisation with C. albicans (Seelig, 1968) . For this reason, such treatment is often recommended as an adjunct to vaginal treatment in patients with recurrent genital infection (Nicol, 1971; Cartwright, 1978 English (1974) .
STATISTICAL METHOD
The results were analysed with the x2 test (with Yates's correction).
Results
The patients were assessed two weeks after treatment was begun and the findings are summarised in Table  2 . In this (Table  3) . Thirteen of these patients required further treatment. Up to eight weeks a further nine patients in group 1 had become reinfected; four of these patients had returned with symptoms and clinical signs of infection and had needed further treatment. Seven patients in group 2 who had returned at four or eight weeks had become reinfected; three of these patients required further treatment. No significant difference in the reinfection rate was detected between the two treatment groups at four or eight weeks.
FAECAL CULTURES
The number of patients in each treatment group with positive faecal culture results before treatment and at two, four and eight weeks is presented in Table 4 . In all, 79 patients had positive faecal culture results before treatment; 20 patients in group I and 24 patients in group 2 had positive faecal culture results before treatment and again two weeks later. No significant differences were detected between the two treatment groups before treatment or at two, four, or eight weeks. 
Discussion
Many clinicians consider simultaneous oral treatment with nystatin to be a useful adjunct to the local treatment of patients with persistent vulvovaginal candidosis on the assumption that such treatment will help to prevent reinfection from the intestinal tract. Most of the patients admitted to this investigation had positive faecal culture results as did most of the patients who became reinfected. In this respect, our findings confirm those of another recent investigation (Miles et al., 1977) .
Our findings indicate that simultaneous oral and vaginal treatment did not bring about a higher cure rate. This is in accordance with the findings of Velupillai and Thin (1977) , who detected no significant difference between the effect of combined local and oral nystatin treatment compared with local nystatin treatment alone. The oral treatment regimen adopted in this investigation has been recommended for the treatment of patients with long-standing vaginal candidosis (Nicol, 1971; Cartwright, 1978) (Rodin and Kolator, 1976) , cannot be discounted.
In conclusion, simultaneous oral treatment with nystatin did not increase the cure rate nor did it decrease the relapse rate in our patients. Prolonged oral treatment with nystatin has helped a number of patients with chronic vulvovaginal candidosis, but this investigation has shown that intestinal colonisation often recurs once oral treatment has been discontinued. If the mouth is the principal source of intestinal colonisation, then eradication of this reservoir of infection might help to reduce the spread of C. albicans. Intermittent prophylactic treatment could be the best means of preventing vulvovaginal infection in predisposed patients. The beneficial effect of intermittent vaginal treatment has been reported (Davidson and Mould, 1978) , but the role of intermittent intestinal treatment remains to be evaluated.
